Report - Dossier zur Nutzenbewertung gemäß § 35a SGB V · Dokumentvorlage, Version vom 18.04.2013 Bristol-Myers Squibb GmbH & Co.KGaA Nivolumab (Opdivo®) Modul 3 G Plattenepithelkarzinom

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form